Session Information

Invited Symposium

[IS-FR-103] New Targets in Retinal Diseases: VEGF and Beyond VEGF
Go back
print
Day
Apr 04 (Fri)
Time
10:30 - 12:00
Room
Room 6 - Tokyo International Forum 5F Hall D5
Topic
Pharmacology, Ocular Drug Delivery
Chair/Coordinator
Chair)Arup Das、Chair)Taiji Sakamoto、Chair)Gursel Yilmaz
Description
The symposium is intended to overview the problem and benefit of corrent anti-VEGF treatment and further show the future therapy beyond anti-VEGF therapy.

Duration 15min (including Q&A)

IS-FR-103-1 / 

Pharmacology, Ocular Drug Delivery

Higher Dose Anti-VEGF Approach

Quan Nguyen

Higher Dose Anti-VEGF Approach

Duration 15min (including Q&A)

IS-FR-103-2 / 

Pharmacology, Ocular Drug Delivery

Long-Acting Anti-VEGF Delivery: How Close Are We?

Roman Rubio

Long-Acting Anti-VEGF Delivery: How Close Are We?

Duration 15min (including Q&A)

IS-FR-103-3 / 

Pharmacology, Ocular Drug Delivery

Is Chronic Use of Anti-VEGF Drugs Toxic to the Eye? New Insights

Toshihide Kurihara

Is Chronic Use of Anti-VEGF Drugs Toxic to the Eye? New Insights

Duration 15min (including Q&A)

IS-FR-103-4 / 

Pharmacology, Ocular Drug Delivery

Systemic Safety of Anti-VEGF Therapy for Ocular Diseases: Should We Be Concerned?

Diana Do

Systemic Safety of Anti-VEGF Therapy for Ocular Diseases: Should We Be Concerned?

Duration 15min (including Q&A)

IS-FR-103-5 / 

Pharmacology, Ocular Drug Delivery

Pericyte: A Novel Target (PDGF)

Donald D'Amico

Pericyte: A Novel Target (PDGF)

Duration 15min (including Q&A)

IS-FR-103-6 / 

Pharmacology, Ocular Drug Delivery

Beyond VEGF: Other Future Targets (Cytokines, Chemokines)

Arup Das

Beyond VEGF: Other Future Targets (Cytokines, Chemokines)

Go back